(Total Views: 718)
Posted On: 10/02/2020 2:57:00 AM
Post# of 154463
Complete guess but with a non-approved drug 5x market cap wouldn't surprise me. With current market cap $14 a share. With covid approval the price should be above that which means they would get all other indications for free,
For distribution possibly 15%-20%, with our royalty payout that would be a pittance.
Big pharma companies probably think they have us over a barrel because of finances. But any deal is probably based on first approval. By then finances are no longer a worry and whatever they offer will be laughable.
For distribution possibly 15%-20%, with our royalty payout that would be a pittance.
Big pharma companies probably think they have us over a barrel because of finances. But any deal is probably based on first approval. By then finances are no longer a worry and whatever they offer will be laughable.
(4)
(0)
